Blockade of p-selectin is sufficient to reduce MHC I antibody-elicited monocyte recruitment in vitro and in vivo.
about
Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte AntigenThe perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejectionMHC class I signaling: new functional perspectives for an old moleculeThe divergent roles of macrophages in solid organ transplantationMonocyte recruitment by HLA IgG-activated endothelium: the relationship between IgG subclass and FcγRIIa polymorphisms.Antibody Subclass Repertoire and Graft Outcome Following Solid Organ TransplantationImmune-mediated vascular injury and dysfunction in transplant arteriosclerosisComplement-Mediated Enhancement of Monocyte Adhesion to Endothelial Cells by HLA Antibodies, and Blockade by a Specific Inhibitor of the Classical Complement Cascade, TNT003Diagnosis and management of antibody-mediated rejection: current status and novel approaches.An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLADonor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver TransplantationAntibodies to HLA Molecules Mimic Agonistic Stimulation to Trigger Vascular Cell Changes and Induce Allograft InjuryInnate immune cells in transplantation.Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms.Macrophages in solid organ transplantation.Transplant glomerulopathy: the interaction of HLA antibodies and endotheliumGraft microvascular disease in solid organ transplantation.Platelet secretion: From haemostasis to wound healing and beyond.Chronic allograft rejection: a fresh look.Innate immunity in solid organ transplantation: an update and therapeutic opportunities.Mechanisms of antibody-mediated acute and chronic rejection of kidney allografts.Humanized Mouse Models for Transplant Immunology.HLA class I antibodies trigger increased adherence of monocytes to endothelial cells by eliciting an increase in endothelial P-selectin and, depending on subclass, by engaging FcγRs.Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies.Long-term graft survival in patients with chronic antibody-mediated rejection with persistent peritubular capillaritis treated with intravenous immunoglobulin and rituximab.AST Cutting Edge of Transplantation 2013 Meeting Report: a comprehensive look at B cells and antibodies in transplantation.Multiplexed color-coded probe-based gene expression assessment for clinical molecular diagnostics in formalin-fixed paraffin-embedded human renal allograft tissue.Outside-in HLA class I signaling regulates ICAM-1 clustering and endothelial cell-monocyte interactions via mTOR in transplant antibody-mediated rejection.HLA Class I and Class II-Induced Intracellular Signaling and Molecular Associations in Primary Human Endothelial Cells.The Role of the Endothelium during Antibody-Mediated Rejection: From Victim to Accomplice.Inflammatory cell burden and phenotype in endomyocardial biopsies with antibody-mediated rejection (AMR): a multicenter pilot study from the AECVP.
P2860
Q26766411-E6F26D82-F62B-4005-8173-B262B6212C4FQ26862195-B98F3092-0C6B-446E-BD5E-28CA42EBC448Q27000194-370A526A-3B10-49F2-892C-33707D6C1902Q27022711-4CF9E708-CF9D-4285-A79C-E68032134CB9Q27314948-EF3E7DE0-C149-4B31-85AD-1988E2ED5DF5Q28076193-7E604871-8DAC-4144-83AF-C8E27DD69A48Q28084366-C7884B90-8FEA-46CB-9F33-B7302811BB99Q33829159-E22619BA-5B2B-4DCD-9744-1E060D3701DCQ34841849-FF22FA43-2571-4CD1-B421-C4E78CC7BAD6Q36302476-C225533A-2E11-4C55-8212-17ACF349A37CQ37616457-D706550F-E45F-4F33-B4C0-6AEC9A09B8EDQ37720377-DBAF2CCD-625A-4536-A2E6-2D65DFE543F9Q38169495-82BD0ADE-93D1-4A8C-A183-E39EAE0064B4Q38169496-7A4B5E3A-8523-48E2-BFF6-27342F59574CQ38194688-942CE3DA-BDEB-4BBE-87F9-0CD99F2109DEQ38205229-EB42A015-8A00-4D04-AB91-3077D7D90192Q38216381-BD720B5E-8D39-4819-9F94-65E7E14961B3Q38281989-316A3BC8-AB96-4E51-9C1D-8161A80110D5Q38309271-E3B3A4FF-82C0-48E6-AF69-AAED710D472EQ38341632-C472678A-BC42-41C5-9472-5530098F057AQ38635500-52928DFA-DBEA-4ADF-BA22-DD5B5C9FB44DQ38640208-1879819A-CD39-45D4-84E9-6265719A13B9Q39149436-C90AAF40-F9DB-42D9-9155-0929D61C1C81Q39366396-B39E0B0E-482E-40EA-A34F-2D2E984F7B03Q40149564-81476685-DF6E-4CC4-926B-C694548EC8CEQ40331013-041E4DB9-BBF8-46CA-845C-F2B6EF97CE0EQ41001433-314FAAD8-3572-43A7-BB8A-A7B1FD4297ACQ46258296-767F3DF6-07F2-4653-8AA2-C33B1EAD89B1Q47673511-30C58DAD-717D-4380-A745-2613D6E73C75Q49521510-17F3D0B8-1D39-443D-9727-D508FD5C9137Q53637925-839A6FD8-2C59-4732-A863-D15C5436E075
P2860
Blockade of p-selectin is sufficient to reduce MHC I antibody-elicited monocyte recruitment in vitro and in vivo.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Blockade of p-selectin is suff ...... ruitment in vitro and in vivo.
@ast
Blockade of p-selectin is suff ...... ruitment in vitro and in vivo.
@en
type
label
Blockade of p-selectin is suff ...... ruitment in vitro and in vivo.
@ast
Blockade of p-selectin is suff ...... ruitment in vitro and in vivo.
@en
prefLabel
Blockade of p-selectin is suff ...... ruitment in vitro and in vivo.
@ast
Blockade of p-selectin is suff ...... ruitment in vitro and in vivo.
@en
P2093
P2860
P356
P1476
Blockade of p-selectin is suff ...... ruitment in vitro and in vivo.
@en
P2093
E Rozengurt
J W Kupiec-Weglinski
M C Fishbein
N M Valenzuela
P2860
P304
P356
10.1111/AJT.12016
P407
P577
2012-12-27T00:00:00Z